Reports have said that Beijing is speaking out against the US court that recently ordered two Chinese manufacturers of Vitamin C to pay $162 million in damages for price-fixing. The US court is now accused of infringing on Beijing’s sovereignty. A spokesman for China’s Ministry of Commerce spoke out against the US court at a press conference, arguing that the ruling was “unfair and improper” and that the accused companies were simply complying with the Chinese government’s requirements. Last week a federal court in New York ordered that North China Pharmaceutical Group Corp and one of its affiliates to pay the fine after the defendants argued that the “price-fixing cartel” found to have existed by the jury was the result of Chinese government decisions. The fines were trebled by the judge.
Featured News
As Congress Considers a Ban On State AI Regs, California and NY Forge Ahead
Jun 19, 2025 by
CPI
Canada Watchdog Calls for Easing Foreign Investment Rules in Airline Sector
Jun 19, 2025 by
CPI
Litigation Finance Battle Heats Up in Tyson Foods Price-Fixing Case
Jun 19, 2025 by
CPI
Spain Weighs Additional Conditions on BBVA’s Hostile Bid for Sabadell
Jun 19, 2025 by
CPI
Japan’s TDK Buys SoftEye to Strengthen Smart Glasses Capabilities
Jun 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Theories of Harm
Jun 17, 2025 by
CPI
What Do We Mean by Harm to the Competitive Process?
Jun 17, 2025 by
Sean Sullivan
Is There a Better Approach to Vertical Merger Analysis?
Jun 17, 2025 by
Bob Majure & Andrew Sfekas
California’s Ill-Advised Turn Toward Europeanized Theories of Harm For Single-Firm Conduct
Jun 17, 2025 by
Geoffrey Manne, Dirk Auer & Brian Albrecht
EU Competition Policy in Support of Democracy and Sustainability: What Theories of Harm When Moving Away From the Predominance of the Consumer Welfare Paradigm?
Jun 17, 2025 by
Marios C. Iacovides